Disease management, outcomes, and healthcare resource utilization in real-life clinical practice of diabetes and diabetic kidney disease in Finland
An erratum to this article was published (Diabetes Res Clin Pract, Jul 2026 ↗)
Authors' conclusion
Individuals with diabetes remain neglected for albuminuria screening, pharmacological management of complications, and also glycemic control in T1D, underlining an urgent need for improved awareness and risk management.
Study context
- Population
- Individuals with T1D or T2D managed since 2008 in Finland
- Outcome
- Prevalence of diabetes
- Follow-up
- 2021
Methodological detailsreal-life clinical practice, nationwide registry data, Finland
- Real-life clinical practice
- Nationwide registry data, Finland
Main finding
As reported in the abstract
Prevalence of diabetes
9.9 %
Observational data: associations, not effects.
Further findings
Annual urine albumin-creatinine ratio (UACR) test adherence
- Completed recommended annual UACR test despite averaging 40-50 healthcare contacts per year
- one-third
- Factors positively associated with UACR test adherence: older age, male sex, T2D, higher HbA1c, municipality, calendar year
HbA1c ≤ 53 mmol/mol
%
- T1D
- 29
- T2D
- 75
SGLT2i use and discontinuation
- Prescribed SGLT2i
- 19 %
- Discontinued SGLT2i within a year
- one-third
- Discontinuation accompanied by a trend towards increased kidney complications and HF
Original publication
Disease management, outcomes, and healthcare resource utilization in real-life clinical practice of diabetes and diabetic kidney disease in Finland. Diabetes Res Clin Pract. Published 21 December 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →